(2-Propylthiazol-4-yl)methanamine → 5-(4-chloro-phenyl)-6-cyclopropylmethoxy-N-(2-propyl-thiazol-4-ylmethyl)-nicotinamide
반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:9]=[C:10]([C:19]([OH:21])=O)[CH:11]=[N:12][C:13]=2[O:14][CH2:15][CH:16]2[CH2:18][CH2:17]2)=[CH:4][CH:3]=1.[CH2:22]([C:25]1[S:26][CH:27]=[C:28]([CH2:30][NH2:31])[N:29]=1)[CH2:23][CH3:24]>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[C:13]([O:14][CH2:15][CH:16]3[CH2:17][CH2:18]3)=[N:12][CH:11]=[C:10]([CH:9]=2)[C:19]([NH:31][CH2:30][C:28]2[N:29]=[C:25]([CH2:22][CH2:23][CH3:24])[S:26][CH:27]=2)=[O:21])=[CH:6][CH:7]=1참가 물질
3
실험 절차
The title compound was synthesized in analogy to Example 1, using 5-(4-chlorophenyl)-6-(cyclopropylmethoxy)-3-pyridinecarboxylic acid (CAS Registry No. 1018782-76-7) and 2-propyl-4-thiazolemethanamine as starting materials, LC-MS (UV peak area/ESI) 99%, 442.134 (M+H)+.
출처 및 근거
- ORD 기록
- ord-e048d940a38a4be99555c992312a9e37
- 출처 데이터셋
- uspto-grants-2014_05